Literature DB >> 22800556

Radiation therapy for cutaneous melanoma.

Christopher A Barker1, Nancy Y Lee.   

Abstract

Radiation therapy is used infrequently for cutaneous melanoma, despite research suggesting benefit in certain clinical scenarios. This review presents data forming the highest level of evidence supporting the use of radiation therapy. Retrospective and prospective studies demonstrate radiation therapy for primary tumors is associated with high control rates. Two randomized trials have found improvements in regional control with adjuvant radiotherapy to regional lymphatics. Retrospective and prospective studies demonstrate radiation therapy is associated with palliative response and metastatic tumor control. Optimal care of melanoma patients involves radiation therapy; awareness of this is incumbent of clinicians caring for patients with this disease.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22800556      PMCID: PMC4667364          DOI: 10.1016/j.det.2012.04.011

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  53 in total

1.  Radiation therapy of primary and metastatic melanoma.

Authors:  W HELLRIEGEL
Journal:  Ann N Y Acad Sci       Date:  1963-02-15       Impact factor: 5.691

2.  Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.

Authors:  Hidefumi Aoyama; Hiroki Shirato; Masao Tago; Keiichi Nakagawa; Tatsuya Toyoda; Kazuo Hatano; Masahiro Kenjyo; Natsuo Oya; Saeko Hirota; Hiroki Shioura; Etsuo Kunieda; Taisuke Inomata; Kazushige Hayakawa; Norio Katoh; Gen Kobashi
Journal:  JAMA       Date:  2006-06-07       Impact factor: 56.272

3.  Treatment of melanotic freckle with x-rays.

Authors:  A W Kopf; R S Bart; A H Gladstein
Journal:  Arch Dermatol       Date:  1976-06

4.  Wide excision without radiation for desmoplastic melanoma.

Authors:  Alisha Arora; Lori Lowe; Lyndon Su; Riley Rees; Carol Bradford; Vincent C Cimmino; Alfred E Chang; Timothy M Johnson; Michael S Sabel
Journal:  Cancer       Date:  2005-10-01       Impact factor: 6.860

5.  Provisional results of treatment of the mélanose précancéreuse circonscrite Dubreuilh by Bucky-rays.

Authors:  W P De Groot
Journal:  Dermatologica       Date:  1968

6.  Carbon dioxide laser treatment for lentigo maligna: a retrospective review comparing 3 different treatment modalities.

Authors:  Haemi Lee; Leigh J Sowerby; Claire L Temple; Edward Yu; Corey C Moore
Journal:  Arch Facial Plast Surg       Date:  2011 Nov-Dec

7.  Radiosurgery versus surgery, both with adjuvant whole brain radiotherapy, for solitary brain metastases: a randomised controlled trial.

Authors:  D E Roos; J G Smith; S W Stephens
Journal:  Clin Oncol (R Coll Radiol)       Date:  2011-05-17       Impact factor: 4.126

8.  Efficacy of radiation therapy in the local control of desmoplastic malignant melanoma.

Authors:  Roy Vongtama; Afshin Safa; David Gallardo; Thomas Calcaterra; Guy Juillard
Journal:  Head Neck       Date:  2003-06       Impact factor: 3.147

9.  Local recurrence in melanoma in situ: influence of sex, age, site of involvement and therapeutic modalities.

Authors:  I Zalaudek; M Horn; E Richtig; S Hödl; H Kerl; J Smolle
Journal:  Br J Dermatol       Date:  2003-04       Impact factor: 9.302

10.  Estimation of an optimal radiotherapy utilization rate for melanoma: a review of the evidence.

Authors:  Geoff Delaney; Michael Barton; Susannah Jacob
Journal:  Cancer       Date:  2004-03-15       Impact factor: 6.860

View more
  8 in total

Review 1.  Current treatment of locoregional recurrence of melanoma.

Authors:  Malcolm Hart Squires; Keith A Delman
Journal:  Curr Oncol Rep       Date:  2013-10       Impact factor: 5.075

Review 2.  Lentigo maligna and lentigo maligna melanoma: contemporary issues in diagnosis and management.

Authors:  Karen L Connolly; Kishwer S Nehal; Klaus J Busam
Journal:  Melanoma Manag       Date:  2015-05-18

Review 3.  Radiotherapy and Immune Checkpoint Blockade for Melanoma: A Promising Combinatorial Strategy in Need of Further Investigation.

Authors:  Freddy E Escorcia; Michael A Postow; Christopher A Barker
Journal:  Cancer J       Date:  2017 Jan/Feb       Impact factor: 3.360

4.  pH-Sensitive Liposomes for Enhanced Cellular Uptake and Cytotoxicity of Daunorubicin in Melanoma (B16-BL6) Cell Lines.

Authors:  Hamad Alrbyawi; Ishwor Poudel; Manjusha Annaji; Sai H S Boddu; Robert D Arnold; Amit K Tiwari; R Jayachandra Babu
Journal:  Pharmaceutics       Date:  2022-05-26       Impact factor: 6.525

5.  Surgical Reconstruction following Wide Local Excision of Malignant Melanoma of the Scalp.

Authors:  Ilaria Baldelli; Maria Lucia Mangialardi; Marzia Salgarello; Edoardo Raposio
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-08-26

6.  In vivo efficacy of nano hyaluronan-conjugated cisplatin for treatment of murine melanoma.

Authors:  Qiuhong Yang; Daniel J Aires; Shuang Cai; Garth R Fraga; Da Zhang; Cicy Z Li; M Laird Forrest
Journal:  J Drugs Dermatol       Date:  2014-03       Impact factor: 2.114

Review 7.  Combinations of radiation therapy and immunotherapy for melanoma: a review of clinical outcomes.

Authors:  Christopher A Barker; Michael A Postow
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-04-01       Impact factor: 7.038

Review 8.  Reversal of Resistance in Targeted Therapy of Metastatic Melanoma: Lessons Learned from Vemurafenib (BRAFV600E-Specific Inhibitor).

Authors:  Antoni Xavier Torres-Collado; Jeffrey Knott; Ali R Jazirehi
Journal:  Cancers (Basel)       Date:  2018-05-24       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.